USPTO serial 98719246
ENDURANCE
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- ALTREE, NICHOLAS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ENDURANCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Norwood, MA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
SARA M DORCHAK
SARA M DORCHAK BARCLAY DAMON LLP1270 AVENUE OF THE AMERICAS, SUITE 501NEW YORK, NY 10020United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | (Based on Use in Commerce) Reagents for research purposes, namely, polymerase chain reaction (PCR) master mixes; (Based on Intent to Use) Chemical preparations for scientific purposes; Chemical reagents; Chemical substances for analyses in laboratories; enzymes for industrial purposes; enzymes for scientific and research purposes; enzymes for the food industry; molecular diagnostic reagents for scientific and research use; nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; all of the foregoing not for medical or veterinary use. | ACTIVE | Mar 3, 2022 |
| 005 | (Based on Use in Commerce) Reagents for medical diagnostic purposes, namely, polymerase chain reaction (PCR) master mixes; (Based on Intent to Use) Diagnostic chemical preparations used by medical laboratories for analyses; Chemical reagents; Diagnostic chemical substances used by medical laboratories for analyses; enzymes for medical and veterinary purposes; medical diagnostic molecular reagents for use in the identification and detection of bacteria, veterinary pathogens and other infectious organisms and the diagnosis of urine infections and autoimmune diseases; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; all of the foregoing for medical or veterinary use. | ACTIVE | Mar 3, 2022 |
| 009 | Based on Use in Commerce) Laboratory consumables, namely, pipettes; (Based on Intent to Use) Laboratory equipment and supplies in the nature of laboratory consumables, namely, pipette tips, trays, filters, droppers, test tubes, bottles, dishes, cell culture dishes, liquid strainers, cell strainers, flasks, tissue culture flasks, polymerase chain reaction (PCR) tubes, polymerase chain reaction (PCR) tube strips, polymerase chain reaction (PCR) plates, deep-well plats, glass stirring tools, spatulas, forceps, tubing in the nature of glass tubes and connectors therefor, single use assemblies in the nature of filters fluid transfer tubing sets, needles and ports, tubing, connectors therefor, and custom hose assemblies being parts and fittings for all of the aforesaid goods; apparatus and instruments for scientific research in laboratories for detection and analysis of nucleic acids, namely, quantitative polymerase Chain Reaction (qPCR) device and lab-on-chips for amplification and detection of DNA and RNA; all of the foregoing not for medical or veterinary use and not including thermometers | ACTIVE | Mar 3, 2022 |
| 010 | (Based on Intent to Use) Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; medical diagnostic apparatus and instruments for detection and analysis of nucleic acids, namely, quantitative polymerase chain reaction (qPCR) device incorporating lab-on-chips for amplification and detection of DNA and RNA | ACTIVE | — |
| 011 | (Based on Intent to Use) laboratory freezers; laboratory refrigerators; refrigerators and freezers for medical storage purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MARATHON LS LLC
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 011
- Similar marks named ENDURANCE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 21, 2026 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Oct 21, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 21, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 21, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 21, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 21, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 3, 2026 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Sep 3, 2026 | PGTT | PETITION GRANTED - TTAB APPEAL FILED | — |
| Sep 2, 2026 | APET | ASSIGNED TO PETITION STAFF | — |
| Aug 7, 2026 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Aug 5, 2026 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jul 14, 2026 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jul 14, 2026 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jul 14, 2026 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Apr 14, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Apr 14, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jan 14, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 14, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 14, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 16, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 16, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 16, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 18, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Sep 18, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Jun 20, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 3, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 27, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 27, 2024 | NWAP | NEW APPLICATION ENTERED | — |